Sanexas Intl. GmbH
Country not established
- Devices
- 1
What Sanexas Intl. GmbH makes
Sanexas Intl. GmbH manufactures the NEOGENESYS 2K, a medical device designed for renal replacement therapy, specifically for continuous blood purification in acute and chronic kidney failure patients.
The NEOGENESYS 2K is classified as a Class II device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Neogenesys 2K Ref K022433
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Sanexas Intl. GmbH have in the registry?
The registry currently lists 1 device for Sanexas Intl. GmbH. Devices recorded under merged duplicate company entries are counted once.
Which registries list Sanexas Intl. GmbH's devices?
Among its 1 most recently registered device, Sanexas Intl. GmbH has devices listed in FDA 510(k) (1 device).
What risk classes do Sanexas Intl. GmbH's devices fall under?
Among its 1 most recently registered device, the classes recorded for Sanexas Intl. GmbH's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Sanexas Intl. GmbH in the registry?
The most recently registered devices listed for Sanexas Intl. GmbH include NEOGENESYS 2K.